PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2149581
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2149581
According to Stratistics MRC, the Global Anesthesia & Respiratory Monitoring Devices Market is accounted for $3.2 billion in 2026 and is expected to reach $6.8 billion by 2034 growing at a CAGR of 9.9% during the forecast period. Anesthesia & Respiratory Monitoring Devices comprise medical technologies designed to track patients' physiological and respiratory conditions during anesthesia, surgery, and intensive care. The category covers anesthesia workstations and monitors, capnography equipment, pulse oximetry devices, respiratory gas analyzers, ventilator monitoring systems, and integrated monitoring solutions. These technologies help clinicians recognize oxygenation problems, ventilation abnormalities, physiological changes, and anesthesia-related risks promptly. Rising surgical activity, stronger patient-safety requirements, expanding intensive-care infrastructure, and advancements in connected and automated monitoring technologies are contributing to broader utilization across healthcare facilities worldwide.
According to WHO, 5 billion people globally lack access to safe, affordable surgical and anaesthesia care, while about 143 million additional surgeries are needed each year. This supports the long-term need for anesthesia-related equipment and monitoring technologies as surgical capacity expands.
Rising surgical procedures and perioperative monitoring requirements
Increasing surgical activity is supporting the adoption of anesthesia and respiratory monitoring devices because healthcare professionals need continuous visibility into oxygen levels, ventilation, cardiovascular parameters, and other vital functions throughout procedures. Population aging and the rising burden of chronic conditions are also increasing the need for surgical and hospital treatments. Meanwhile, stronger attention to perioperative safety encourages earlier recognition of physiological changes. Consequently, hospitals, ambulatory surgical centers, and other healthcare facilities are increasingly incorporating sophisticated monitoring technologies to improve continuous observation and support clinical decision-making.
High cost of advanced monitoring equipment
Expensive advanced monitoring technologies can limit the adoption of anesthesia and respiratory monitoring devices, especially in smaller hospitals, outpatient facilities, and institutions facing financial constraints. Modern systems may involve significant spending on equipment acquisition, software, installation, integration, and workforce training. Ongoing costs for maintenance, calibration, replacement parts, and technology upgrades can further raise ownership expenses. As a result, some healthcare providers may retain existing conventional monitoring systems for longer periods, postponing modernization initiatives and restricting the penetration of sophisticated monitoring solutions in price-sensitive healthcare markets worldwide.
Expansion of remote and connected patient monitoring
Growing adoption of connected and remote healthcare models offers opportunities for manufacturers of anesthesia and respiratory monitoring devices to introduce solutions capable of collecting and transmitting patient data across different care settings. Wireless technologies, cloud platforms, wearable sensors, and remote-access capabilities can facilitate observation during recovery, intensive care, and selected home-care applications. Linking monitoring technologies with electronic health records and telehealth systems may improve clinician access to patient information. This shift toward connected care creates opportunities for interoperable devices, digital platforms, and remote monitoring services.
Cybersecurity and data privacy risks
Greater connectivity across anesthesia and respiratory monitoring technologies increases exposure to cybersecurity and patient-data protection challenges. Devices connected to hospital networks, cloud environments, and remote monitoring platforms can potentially face unauthorized access, malicious software, or information breaches. Growing integration with digital healthcare infrastructure requires manufacturers to improve authentication, encryption, software maintenance, and overall security capabilities. Security incidents may result in higher compliance expenses, operational interruptions, reputational concerns, and reduced confidence among healthcare providers, potentially creating obstacles to broader adoption of connected monitoring solutions.
COVID-19 influenced the Anesthesia & Respiratory Monitoring Devices Market by creating substantial requirements for respiratory monitoring technologies across intensive-care units and emergency departments. Healthcare facilities increased utilization of pulse oximetry, capnography, ventilator monitoring systems, and multiparameter monitoring equipment for patients with serious respiratory conditions. Manufacturers also encountered supply chain interruptions and production challenges. Later investments in critical-care infrastructure and pandemic preparedness supported continued attention toward advanced respiratory monitoring technologies.
The critical care segment is expected to be the largest during the forecast period
The critical care segment is expected to account for the largest market share during the forecast period due to the intensive monitoring requirements of critically ill patients. Intensive care settings routinely manage individuals with serious respiratory problems, complicated recovery needs, and unstable physiological conditions, generating consistent demand for monitoring technologies. Capnography equipment, pulse oximetry, ventilator monitoring systems, and multiparameter platforms are important components of critical-care practices. Continuous patient observation, timely detection of physiological changes, and effective respiratory management contribute to widespread use of these monitoring devices in critical-care environments.
The home care settings segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home care settings segment is predicted to witness the highest growth rate as healthcare delivery increasingly moves toward convenient, decentralized care. The adoption of portable, connected, and user-friendly monitoring technologies is expanding opportunities for monitoring patients outside traditional hospital environments. Remote monitoring solutions, wearable devices, wireless communication, and digital healthcare platforms enable clinicians to maintain patient oversight from a distance. Efforts to minimize hospital stays, enhance patient convenience, and facilitate ongoing respiratory management are also supporting this segment's expansion.
During the forecast period, the North America region is expected to hold the largest market share due to its developed healthcare infrastructure, technologically advanced hospitals, and extensive use of modern medical equipment. Monitoring technologies are widely required across operating rooms, intensive-care units, and emergency departments. The region utilizes respiratory gas monitors, anesthesia workstations, ventilator monitoring solutions, and integrated patient-monitoring platforms. Established safety standards and regulatory requirements further support adoption of sophisticated devices. Together, these factors contribute to strong utilization of anesthesia and respiratory monitoring technologies throughout North American healthcare facilities.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving healthcare infrastructure, rising medical expenditure, and increasing investment in healthcare technologies. Developing healthcare systems across the region are expanding hospital capacity and adopting modern monitoring solutions. Growing requirements for surgical procedures, intensive care, and respiratory management are further supporting demand. According to OECD and WHO, healthcare spending has increased across Asia Pacific, while several countries are strengthening capital investment in healthcare equipment and technology, creating favorable conditions for monitoring-device adoption.
Key players in the market
Some of the key players in Anesthesia & Respiratory Monitoring Devices Market include Medtronic, GE HealthCare, Drager, Masimo, Nihon Kohden, Philips, Mindray, Schiller, Nonin Medical, Infinium Medical, Fukuda Denshi, Spacelabs Healthcare, Edan Instruments, Shenzhen Comen Medical Instruments, B. Braun, Getinge, Criticare Systems and Heyer Medical.
In April 2026, GE HealthCare announced an expanded collaboration with DeepHealth, Inc, to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and women's health.
In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.